9 weeks that matter for patients with gastric cancer

0
0 / 5 (0 votos)

The Lancet Oncology

Fecha de publicación: 21 october 2018

DOI: https://doi.org/10.1016/S1470-2045(18)30752-6

Autores: Henrik Nienhüser, Thomas Schmidt

Background: Unresectable advanced or metastatic gastric cancer remains a difficult-to-manage disease, with poor median overall survival associated with first-line and second-line palliative systemic treatment. 

Seguir leyendo